AN2 Therapeutics | IPO Presentation Deck | 27 slides · page 7 of 27
The slide highlights the lineage of the boron chemistry platform and the transition of assets from Anacor/Pfizer to AN2 Therapeutics.
Pitch deck · timeline · cite_precedent · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 4
timeline paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1